Marinus Pharmaceuticals (MRNS) PT Raised to $29 at Jefferies After PCDH19 Data
Tweet Send to a Friend
Jefferies analyst Andrew Tsai raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $29.00 (from $24.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
